Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - OTHER LONG-TERM ASSETS
Other Long-term Assets AKBA - Akebia Therapeutics, Inc.
12.4 M
LAST VALUE
-50.03%
2 YEAR CAGR
-10.64%
5 YEAR CAGR
26.29%
10 YEAR CAGR